2016
DOI: 10.19106/jmedsci004803201605
|View full text |Cite
|
Sign up to set email alerts
|

The effect of mitomycin-c in keloid fibroblast cultures

Abstract: Keloid occurs due to hyperactivity of keloid fibroblast (KF) in proliferation, migration, collagen deposition, together with low rates of collagen degradation. These are under the responsibility of TGF-b. Mitomycin C (MC) is used for treating keloid by a topical application during surgery at the level of 0.02% to 0.08%. Unfortunately, the lowest effective level of MC for keloid has not been determined yet. We aimed to determine the lowest effective level of MC in the suppression of KF activities. Various level… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 22 publications
0
2
0
Order By: Relevance
“…For example, Richard et al [20] indicated that mitomycin-C could inhibit KF proliferation by suppressing DNA synthesis. Dachlan et al [17] showed that 30 uM mitomycin-C could suppress keloid fibroblast proliferation and collagen synthesis. Both studies are based on Stewart et al [8] who used topical application of mitomycin-C for clinical wound repair trials to prevent keloid.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, Richard et al [20] indicated that mitomycin-C could inhibit KF proliferation by suppressing DNA synthesis. Dachlan et al [17] showed that 30 uM mitomycin-C could suppress keloid fibroblast proliferation and collagen synthesis. Both studies are based on Stewart et al [8] who used topical application of mitomycin-C for clinical wound repair trials to prevent keloid.…”
Section: Discussionmentioning
confidence: 99%
“…Both materials were diluted in DMEM containing 10% fetal bovine serum plus 1% penicillin/streptomycin in various concentrations. We used the lowest effective dose of mitomycin-C (30 μM) as previously reported by Dachlan et al [17] as the positive control. To determine the effective dose of 5α-oleandrin, we diluted 5α-oleandrin into various concentrations, and the highest dose was considered to be half of the dose of mitomycin-C.…”
Section: Methodsmentioning
confidence: 99%